Immunoglobulin G Complexes from Post-infectious ME/CFS, including post-COVID ME/CFS Disrupt Cellular Energetics and Alter Inflammatory Marker Secretion
Long Covid/PASC (general)
Long COVID Defense Series II featuring 4 Virtual Q&A Sessions — Mask Together America
400M people worldwide have #LongCOVID. Is it appropriate or excessive to routinely wear a close-fitting respirator in public for protection? Prof. Iwasaki @VirusesImmunity said it makes sense to #MaskUp, get boosted and clean the air. Watch the forum:
Trump policies at odds with emerging understanding of COVID's long-term harm
Dual use of combustible and heated tobacco products associates persistent symptoms with a history of COVID-19: a JASTIS 2023 cross‑sectional study
“persistent symptoms were significantly elevated for four symptoms—arthralgia, chest pain, dyspnea, and dysosmia—compared to never smokers.”
Healthcare Workers With Long COVID Struggle to Find Support
SARS-COV-2 re-infection and incidence of post-acute sequelae of COVID-19 (PASC) among essential workers in New York: a retrospective cohort study
Long-COVID research just got a big funding boost: will it find new treatments?
A role for chronic inflammation in long COVID
Researchers find more long COVID than expected in WA Hispanics
Long Covid stole my pro cycling dream – but what I gained in the process really surprised me
Workplace exposures tied to higher risk of long COVID | CIDRAP
Study of 2,054 workers in Spain (2020–23) found nearly 1 in 4 (23.7%) developed long COVID.
People in high-exposure jobs face a 44% higher risk of long COVID — health care and social workers, teachers, retail workers, transport workers, and security staff.
Metformin at the time of Covid-19 infection and risk of Long Covid: A Target Trial Emulation Study
A new study finds that people on #metformin at the time of COVID-19 infection had a significantly lower risk of developing #LongCOVID.
➡️ Compared with non-users, metformin users saw a ~53% reduction in LongCOVID risk — a major drop, if confirmed.
Long-COVID research just got a big funding boost: will it find new treatments?
“the German government has announced that it will provide €500 million (US$582 million) in research funding to support a National Decade Against Post-Infectious Diseases from 2026 to 2036.. Germany is one of many countries facing an unprecedented health burden owing to long COVID and other post-infection syndromes since the COVID-19 pandemic.. Almost one in five people in a German cohort had long COVID in 2022.. The German government aims to fund research into a wide variety of post-infectious diseases, including Long COVID and ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome).."
The lingering shadow of epidemics: post-acute sequelae across history
Yale scientists reviewed 100 years of records and found that Long COVID is part of a larger pattern.
Viruses like polio, SARS, and EBV have long caused lasting illness in some people, often through immune dysfunction
Don't accept an incomplete and nonspecific diagnosis any longer, of just:
“Don't accept an incomplete and nonspecific diagnosis any longer, of just: Long COVID Take the next step in identifying if your symptoms are due to tissue Hypoxia (associated with persistent endotheliitis)= hLC. We have simplified how to make this diagnosis, using the HHM Test Questionnaire, which you can answer from home. It only takes a few minutes:”
I have long Covid. Don’t call my chronic disease a ‘journey’
Long COVID’s hidden toll: the South Africans still battling fatigue, anxiety and memory loss
Thread by @atranscendedman on Thread Reader App
3rd Long COVID International Conference 2025
3rd Long COVID International Conference 2025
#LongCOVID can take eight different trajectories:
“The researchers identified 8 different longCOVID trajectories. Some of these trajectories included persistently severe symptoms, intermittently severe symptoms, gradually improving symptoms, gradually worsening symptoms, and mild symptoms that only appeared after 15 months.”
Women are three times more likely than men to get severe long COVID: Here’s why
Women are three times more likely than men to get severe long COVID: Here’s why
Women are three times more likely than men to get severe long COVID: Here’s why
New molecular drivers of long COVID link nasal inflammation to lingering symptoms
The study identified two messenger substances that cause persistent inflammation in the nasal mucosa. This inflammatory process appears to inhibit tissue regeneration and thus contributes to the ongoing symptoms of post-COVID syndrome.
Exploring predictors of post-COVID-19 condition among 810 851 individuals in Sweden
“In this large population-based cohort study, our exploratory analysis reveals several risk factors for being diagnosed with PCC. Our findings can serve as a basis for future targeting of preventive measures against PCC.”
Immunological associations in post-infective fatigue syndromes including Long COVID—a systematic review and meta-analysis
“These findings provide cautious support for persistent immune activation in PIFS, but warrant further replication. Future studies should include better documentation of acute infection and PIFS case characterisation.”
Beyond all reason
“Long COVID patients are constantly harangued about our requests for COVID safety. Yet what we're asking for is far less than what we're called on to do to survive.”ju
Long Covid Is Real -- And It's Changing an Entire Generation
“Hundreds of thousands of kids in America are struggling with an illness that many doctors and schools refuse to recognize”
Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS‐CoV‐2 Omicron wave: a cross‐sectional survey
"56% of Australians suffering from long COVID still had persistent symptoms 6 months after their initial infection, according to a new study from the Australian National University (ANU)"
Factors associated with persistence or recovery from long COVID 6 months post-SARS-CoV-2 infection | Epidemiology & Infection | Cambridge Core
"56% of Australians suffering from long COVID still had persistent symptoms 6 months after their initial infection, according to a new study from the Australian National University (ANU)"
Thread by @cbarbermd on Thread Reader App
Potential Long Covid treatment: “About 6 weeks ago, he started Dr. Skip Pridgen’s antiviral protocol: Valtrex, Celebrex & Paxlovid.”
About 6 weeks ago, he started Dr. Skip Pridgen’s antiviral protocol: Valtrex, Celebrex & Paxlovid.
Soluble IL‐2R: A potential therapeutic target for mitochondrial dysfunction in post‐COVID fatigue syndrome
Kentucky researchers studied 11 people with post-COVID fatigue and 17 healthy adults.
They found a five-log rise in soluble IL-2 receptor levels that directly damaged muscle mitochondria, suggesting a new drug target for long COVID fatigue.
Review of organ damage from Covid and Ling Covid